MRK/Isentress One more thing I can think of is if they have learned from previous trials that qD may work fine for patients with relatively low viral loads and will enroll only those in the new trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.